Lydia Shotton is a consultant at APCO and is based in Brussels, where she advises pharmaceutical and nonprofit clients on EU policy developments, particularly in the area of digital health, personalized health care, health care sustainability and non-communicable diseases.
Prior to joining APCO, Ms. Shotton gained experience in public affairs working for a Brussels-based consultancy, where she primarily specialized in multi-stakeholder coalitions focused on the use of real-world evidence to support health technology assessment bodies and payers’ decisions regarding highly innovative technologies and on public-private collaborations in the rare diseases’ community. She also developed in-depth knowledge of the key EU health policy legislations.
Ms. Shotton holds a Bachelor of Science in Neuroscience and a Master of Laws in Medical Law and Ethics from the University of Edinburgh, as well as a Master of Science in Health Economics, Policy and Management from the Karolinksa Institutet in Sweden. A British and Greek national, she speaks English, French and Greek.
